| Literature DB >> 28336945 |
Katharina Hellbach1, Andre Yaroshenko2, Konstantin Willer2, Thomas M Conlon3,4, Margarita B Braunagel5, Sigrid Auweter5, Ali Ö Yildirim3,4, Oliver Eickelberg3,4, Franz Pfeiffer2, Maximilian F Reiser5,4, Felix G Meinel5,4.
Abstract
The aim of this study was to evaluate whether diagnosing pulmonary fibrosis with projection radiography can be improved by using X-ray dark-field radiograms. Pulmonary X-ray transmission and dark-field images of C57Bl/6N mice, either treated with bleomycin to induce pulmonary fibrosis or PBS to serve as controls, were acquired with a prototype grating-based small-animal scanner. Two blinded readers, both experienced radiologists and familiar with dark-field imaging, had to assess dark-field and transmission images for the absence or presence of fibrosis. Furthermore readers were asked to grade their stage of diagnostic confidence. Histological evaluation of the lungs served as the standard of reference in this study. Both readers showed a notably higher diagnostic confidence when analyzing the dark-field radiographs (p < 0.001). Diagnostic accuracy improved significantly when evaluating the lungs in dark-field images alone (p = 0.02) or in combination with transmission images (p = 0.01) compared to sole analysis of absorption images. Interreader agreement improved from good when assessing only transmission images to excellent when analyzing dark-field images alone or in combination with transmission images. Adding dark-field images to conventional transmission images in a murine model of pulmonary fibrosis leads to an improved diagnosis of this disease on chest radiographs.Entities:
Mesh:
Year: 2017 PMID: 28336945 PMCID: PMC5428481 DOI: 10.1038/s41598-017-00475-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Dark-field and transmission images of fibrotic and healthy murine lungs. Representative pictures of a transmission image (left) and dark-field image (middle) of a healthy (upper row) and fibrotic lung (lower row). Histology (right) serves as the gold standard.
Figure 2Quantitative evaluation of absorption and dark-field signal intensities. Comparison of absorption signal intensities of healthy control lungs (white column) with fibrotic lungs (grey column) did not show a statistically significant difference (A). In the corresponding dark-field images fibrotic lungs showed a significantly decreased dark-field signal intensity compared to healthy lungs; *p < 0.001 (B).
Diagnostic accuracy for separate analysis of transmission and dark-field images as well as combined readings.
| Imaging modality | Sensitivity (95% Confidence Interval) | Specificity (95% Confidence Interval) | AUC | p-value* |
|---|---|---|---|---|
| Transmission | 84.4 (67.2–94.7) | 95.8 (78.9–99.9) | 0.90 | |
| Dark field | 96.9 (83.8–99.9) | 100.0 (85.8–100.0) | 0.98 | 0.02 |
| Transmission and Dark-field | 100.0 (89.1–100.0) | 100.0 (85.8–100.0) | 1.0 | 0.01 |
AUC: Area Under the Curve. *Test for significance between transmission and dark-field readings or transmission and combined image analysis.
Diagnostic confidence indicated by reader 1 and reader 2 for interpretation of transmission and dark-field images, either evaluated separately or combined.
| Diagnostic confidence | Transmission | Dark field | Transmission and Dark field |
|---|---|---|---|
| Reader 1 | 1.6 ± 0.9 | 2.7 ± 0.5 | 2.7 ± 0.5 |
| Reader 2 | 1.9 ± 0.8 | 2.7 ± 0.8 | 2.6 ± 0.8 |